Aptevo Therapeutics Inc.

Aptevo to Present CD40 Multispecific Cancer Platform
TipRanks · 14 Oct 2026
Two immune defenses are central to an approach Aptevo will present at a cancer meeting.
Stock Titan · 14 Oct 2026
Aptevo Therapeutics (APVO) Ticks Higher: Shares Gain 1.41% to $1.80 as Range Persists - Outside Reversal
https://www.siam.in/ · 05 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.